FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4298139200> ?p ?o ?g. }

• W4298139200 endingPage "333" @default.
• W4298139200 startingPage "333" @default.
• W4298139200 abstract "333 Background: Family history screening for malignancies informs the need for genetic testing of cancer patients and their families. Associations between heritable mutations and solid malignancies are well-established, but germline contributions to hematologic malignancies may be of similar importance. For instance, the pooled risk of a group of heritable transcription factor mutations including RUNX1, GATA2, and CEBPA may play a role in up to 15% of new cases of leukemia. Standard of care for new patient visits in malignant hematology clinics should involve thorough family screening like that of solid malignancies more classically associated with heredity. Methods: All patients presenting to an academic hospital system's outpatient GI, breast, and leukemia clinics for new patient visits in a 3-month period were identified accounting for 706 participants (breast n=258 (36.5%), GI n=303 (42.9%), leukemia n=145 (20.5%)). Retrospective chart review was completed by EMR report, which aggregated data from individuals identified by their cancer diagnosis. Groups were compared along the following variables: percentage with completed 1 st degree (parents and siblings) family history of malignancy screening, percentage with completed 2 nd degree (grandparents, aunts, and uncles) family history screening. Chi-squared significance testing was completed to identify significant (p<0.05) differences in screening, which was considered completed if entered in the searchable summary information of the patient’s chart. Results: Patients presenting for new patient visits in breast (77.1%) cancer clinic had significantly higher rates of 1 st degree family history of malignancy screening than those presenting with new diagnoses of leukemia (62.1%). The comparison of 1 st degree screening for GI (71.6%) cancer patients and leukemia patients was not significant. Rates of 2 nd degree family history screening were significantly higher for patients with new diagnoses of breast (61.6%) and GI (37.0%) cancers as compared to those with leukemia (24.8%). The combined cohort of GI and breast cancer patients had significantly greater rates of 1 st (74.2%) and 2 nd degree (48.4%) family history screening than patients with new diagnosis of leukemia. Conclusions: There is growing appreciation of heritable germline contributors to leukemia pathogenesis. However, there remains a deficit in clearly documented, easily referenced family history screening for malignancies in patients with new diagnoses of leukemia when compared to patients with new diagnoses of classically heritable solid malignancies.[Table: see text]" @default.
• W4298139200 created "2022-10-01" @default.
• W4298139200 creator A5044943285 @default.
• W4298139200 creator A5050303546 @default.
• W4298139200 creator A5087097104 @default.
• W4298139200 date "2022-10-01" @default.
• W4298139200 modified "2023-09-27" @default.
• W4298139200 title "Family history screening following new diagnoses of leukemia versus solid malignancies." @default.
• W4298139200 doi "https://doi.org/10.1200/jco.2022.40.28_suppl.333" @default.
• W4298139200 hasPublicationYear "2022" @default.
• W4298139200 type Work @default.
• W4298139200 citedByCount "0" @default.
• W4298139200 crossrefType "journal-article" @default.
• W4298139200 hasAuthorship W4298139200A5044943285 @default.
• W4298139200 hasAuthorship W4298139200A5050303546 @default.
• W4298139200 hasAuthorship W4298139200A5087097104 @default.
• W4298139200 hasConcept C121608353 @default.
• W4298139200 hasConcept C126322002 @default.
• W4298139200 hasConcept C143998085 @default.
• W4298139200 hasConcept C187212893 @default.
• W4298139200 hasConcept C2778461978 @default.
• W4298139200 hasConcept C2779399171 @default.
• W4298139200 hasConcept C2781179581 @default.
• W4298139200 hasConcept C530470458 @default.
• W4298139200 hasConcept C71924100 @default.
• W4298139200 hasConceptScore W4298139200C121608353 @default.
• W4298139200 hasConceptScore W4298139200C126322002 @default.
• W4298139200 hasConceptScore W4298139200C143998085 @default.
• W4298139200 hasConceptScore W4298139200C187212893 @default.
• W4298139200 hasConceptScore W4298139200C2778461978 @default.
• W4298139200 hasConceptScore W4298139200C2779399171 @default.
• W4298139200 hasConceptScore W4298139200C2781179581 @default.
• W4298139200 hasConceptScore W4298139200C530470458 @default.
• W4298139200 hasConceptScore W4298139200C71924100 @default.
• W4298139200 hasIssue "28_suppl" @default.
• W4298139200 hasLocation W42981392001 @default.
• W4298139200 hasOpenAccess W4298139200 @default.
• W4298139200 hasPrimaryLocation W42981392001 @default.
• W4298139200 hasRelatedWork W2013945615 @default.
• W4298139200 hasRelatedWork W2023425329 @default.
• W4298139200 hasRelatedWork W2136583131 @default.
• W4298139200 hasRelatedWork W2300712209 @default.
• W4298139200 hasRelatedWork W2314332369 @default.
• W4298139200 hasRelatedWork W2586112515 @default.
• W4298139200 hasRelatedWork W2982258588 @default.
• W4298139200 hasRelatedWork W377899687 @default.
• W4298139200 hasRelatedWork W4293229760 @default.
• W4298139200 hasRelatedWork W2183938888 @default.
• W4298139200 hasVolume "40" @default.
• W4298139200 isParatext "false" @default.
• W4298139200 isRetracted "false" @default.
• W4298139200 workType "article" @default.